LETTERS FOR ISSUE ON

Similar documents
LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

TODAY LETTER DATED

File no./drug Name Name of firm/ Institute Recommendations. New Drugs Division

Recent trends and challenges

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA

Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015. Human vaccines

RESULTS AND DISCUSSION

Subsequent New Drugs Division. M/s.Troikaa. M/s. Olive Healthcare. Biological Division. M/s. Wockhardt Ltd. Global Clinical Trial Division

TRADE MARKS REGISTRY AHMEDABAD

Education. Current Activities

3. Dr.Rajutitus Chacko, Prof. & Head, Dept. of Medical Oncology, CMC, Vellore.

Minimumum Price (Rs.) 3.30 Maximum Price (Rs.) 4.57 Average of all considered (Rs.) 3.73 Retail Price (Rs.) 4.33

Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016

TRADE MARKS REGISTRY AHMEDABAD

AGENDA PAPERS FOR THE EIGHTEENTH MEETING SUB-COMMITTEE ON LARGE ANIMALS (SCLA)

10 th SEC- (Reproductive & Urology)meetingheld on at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi PROGRAMME SCHEDULE

BRIC DIABETES DRUGS MARKET

GLOBAL MARKETS FOR DIABETES THERAPEUTICS AND DIAGNOSTICS

PDF of Trial CTRI Website URL -

Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic

Companies Database, Mobile Database, Id Database, Credit

Ameya works predominantly in the architectural design, interiors and project management segments in healthcare industry

Aina Blood Monitoring System

Solvay in India January, 2014

Exporting Heart Disease to Developing Countries: India. Zeeshan Ali, Ph.D.

PDF of Trial CTRI Website URL -

Segment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage

CAREER AIM POSTGRADUATE TRAINING & EXPERIENCE

Recommendations of thesec (Dermatology & Allergy) made in its 23 rd meeting held on at CDSCO HQ New Delhi: New Drugs Division

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA

INDICATIVE SEAT MATRIX - NBE FET CENTRALIZED COUNSELING 2016 ADMISSION SESSION ROUND-2

ORDER. Table. (1) (2) (3) (4) (5) (6) 1. Glimepiride Metformin Tablet

CANCER INSTITUTE (WIA) CANAL BANK ROAD, ADYAR, CHENNAI

REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38

REF/2014/04/ CTRI Website URL -

GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES

Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on and recommended the following:-

Case 1:14-cv LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023

New Drugs Division. Frequently Asked Questions (FAQs) on Approval of new Phytopharmaceutical Drugs

Central Inspection Plan Using Risk Based Approach Of Vaccine Manufacturing Units for 2017

Hyderabad, India Delegates. April 27, Tentative program A comprehensive Bioanalysis conclave. Key notes.

CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...

PDF of Trial CTRI Website URL -

New: Li st of TPAs List of TPA's released by IRDA Updated C on Oct lick Here.

TABLE 7 ADVANTAGES AND DISADVANTAGES OF TOXOID VACCINES SUBUNIT VACCINES Applications of Subunit Vaccines TABLE 8 APPLICATIONS OF

Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 30/04/2016 to 20/12/2016

Partial Table of Contents (Contact Client Services to receive complete Table of Contents) IV. Design Criteria for Decentralized Testing Products

Molecular Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 Hexa Research

WHO list of prequalified in vitro diagnostic products

Mud/double Pot Hole/ Natural Draft / chimney. Model: 2-Pot hole raised type Mud ICS. Safety. Mud/double Pot Hole/ Natural Draft / chimney

SEAT MATRIX - FELLOWSHIP PROGRAMMES - CENTRALIZED COUNSELING ADMISSION SESSION. Andhra Pradesh. Andhra Pradesh. Andhra Pradesh.

Partial Table of Contents (Contact Client Services to receive complete Table of Contents) IV. Design Criteria for Decentralized Testing Products

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES

INTRAVENOUS (IV) THERAPY AND VEIN ACCESS: GLOBAL MARKETS

PDF of Trial CTRI Website URL -

RENAL BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS

SAMPLE. Asia-Pacific Drug Delivery Devices Market Outlook to Metered Dose Inhaler Devices, Infusion Systems, Central Venous

Decisions taken in the 63 rd Meeting of the Genetic Engineering Approval Committee (GEAC) held on 8 th February 2006.

List of Ordinary Members as on NAME OF THE COMPANY 1 AADIVIGHNESH CHEM PVT LTD 2 AANJANEYA LIFECARE LTD 3 AARTI DRUGS LTD 4 ACCENT

SAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB

Global Aspergillosis Drugs Market Professional Survey Report 2016

Directorate General of Health Services Office of Drugs Controller General (India) (Biological Division)

Vaccine Technologies and Global Markets

M E D I C A L L A B O R A T O R Y

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL -

INDIAN SOCIETY FOR CLINICAL RESEARCH 11th Annual ISCR Conference Collaborative Clinical Research for better Patient outcomes January, 2018

PDF of Trial CTRI Website URL -

Case 3:15-cv PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )

Commentary by R. Little, Ph.D., NGSP Network Coordinator for the NGSP Steering Committee

Tamsulosin Hydrochloride 0.4 mg Capsule

TOTAL MAT 1,52,81, % Unit PTR (Rs.) MAT (Rs.) SKU wise MAT % प क व रण Pack Description छ प BRAND. क पन Company. S. No. Unique No.

WHO list of prequalified in vitro diagnostic products

Nitrazepam. Nitrazepam Tablets TAJ GROUP PHARMACEUTICAL B U S I N E S S. Generics. Active Ingredients: Each tablet contains 10 mg Nitrazepam

WHO list of prequalified in vitro diagnostic products

DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC)

Lists of Nepal Interim Benchmark for solid biomass Cook stoves (NIBC, 2016) approved biomass cook stoves (Tested by RETS)

Blood Glucose Test Strip Market Research Report- Global Forecast till 2020

Global Vitamin Market Professional Survey Report 2016

WHITE PAPER 3D PRINTED SURGICAL GUIDES AND MEDICAL INSTRUMENTS

1. Dr. Shyam Agarwal, Joint Secretary, Department of Commerce. 2. Shri A.K. Bamba, Director, Department of Commerce

100 Abbott Park Road Abbott Park, IL Trade Name: ARCHITECT HIV Ag/Ab Combo Assay Approved Date: 18-JUN-2010

Excipient Regulations Perspective & Creation of IPEC India (Current Regulations & Emerging challenges for excipient regulations in India)

### About Bharat Biotech

Regulatory Reforms-Future of Plasma Protein Therapy in India

Transcription:

S FOR ISSUE ON 17.07.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY TYPE OF NO. 1. M/S. CIREX PHARMACEUTICALS LTD - QUERY 2. M/S. LUPIN LIMITED - ADDITIONAL SITES REGISTRATION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. INTAS PHARMACEUTICAL 6613 APPROVAL /CLARIFICATION 2. DIVINNE SBR ITERNATIONAL PVT. 5243 CLARIFICATION IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. MEHTA PHARMACEUTICAL 20146 CLARIFICATION INDUSTRIES 2. AQUATIC REMEDIES PVT. 19960 CLARIFICATION 3. NOVARTIS HEATLHCARE PVT. 20010 CLARIFICATION 4. SKIES 20116,20134 02 CLARIFICATION 5. RIOTH HEALTHCARE PVT. 20124 CLARIFICATION 6. MICRO LABS 20143 CLARIFICATION 7. PIRAMAL ENTERPRISES 20125 CLARIFICATION 8. BRENNTAG INGREDEINTS 20190 CLARIFICATION

9. UNIMAX CHEMICALS 20094 CLARIFICATION 10. MEHTA PHARMACEUTICAL INDUSTRIES 20152 CLARIFICATION COSMETIC DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. DESIGN, ADARSH NAGAR, DELHI 10602 APPROVAL 2. M/S. ARCHIES LIMITED, NEW DELHI 12484 APPROVAL 3. M/S. SHISEIDO INDIA PVT. LTD, MUMBAI 14704 APPROVAL 4. M/S. WIPRO ENTERPRISES LIMITED, BANGALORE 14847 APPROVAL 5. M/S. GILLETTE INDIA LIMITED, MUMBAI 16066 APPROVAL 6. M/S. DIVINE CARE, CHENNAI 16756 DEFICIENCY SUBSEQUENT NEW DRUG S. NO. NAME OF THE FIRM REFERENCE NO. FTS NO. TYPE OF 1. M/SINTAS 18978 31440 CT NOC PHARMACEUTICALS 2. M/S SUN PHARMA 16497 27453 AMENDMENT 3. M/S TROIKAA PHARMA 14429 23968 DEFICIENCY 4. M/S BAYER 9876 15295 DEFICIENCY PHARMACEUTICALS 5. M/S ABOTT 20988 34910 DEFICIENCY HEALTHCARE 6. M/S ALLERGAN INDIA 18973 31444 DEFICIENCY 7. M/S ALCON LABORATORIES 20280 3337 TEST LICENSE

BA/BE DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. 01 M/S. QPS BIOSERVE INDIA PVT., HYDERABAD 02 M/S. BIOANALYTICAL LABORATORY, GRAND CENTRE, PANACEA BIOTECH, MUMBAI STATUS APPROVAL QUERY 03 M/S. LAMBDA THERAPEUTIC RESEARCH, MUMBAI 21255 QUERY LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. SUN PHARMACEUTICALS, GUJARAT 02 M/S. SHREE KRISHNA KESHAV, GUJARAT 34418 APPROVAL 34167 APPROVAL VACCINE DIVISION S. NO. COMPANY NAME DY. NO. STATUS 1 M/S SERUM INSTITUTE OF INDIA 2 M/S RELIANCE LIFE SCIENCES PVT,,LTD 34187 (FTS NO) APPROVAL 35431 (FTS NO) APPROVAL 3 M/S CADILA HEALTHCARE LIMITED 32738, 32741, 33938, 32742 (FTS NO) APPROVAL 4 M/S NOVO MEDI SCIENCES CLARIFICATION

PVT, LTD 5 M/S INTERVET INDIA PVT, LTD 21431, 9003 CLARIFICATION 6 M/S FRONTIER LIFELINE 15790 CLARIFICATION 7 M/S REGENERATIVE MEDICAL SERVICES PVT. LTD 8 M/S INTAS PHARMACEUTICALS 9 M/S NOVO NORDISK INDIA PVT, LTD 19377 CLARIFICATION 16138 CLARIFICATION 21912 APPROVAL 10 M/S GLOBION INDIA PVT, LTD CLARIFICATION 11 M/S WOCKHARDT LTD CLARIFICATION 12 M/S BIOLOGICAL E. LTD 34858 (FTS NO) APPROVAL 13 M/S L.V. PRASAD EYE INSTITUTE 14 M/S BHARAT SERUM AND VACCINE LTD 53077 APPROVAL 21263 CLARIFICATION MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ARTHOPLASTY 17238 APPROVAL (F-IL) 2. M/S. BARD INDIA HEALTHCARE PVT. 17309 APPROVAL (F-RC) 3. M/S. BARD INDIA HEALTHCARE PVT. 17309 APPROVAL (F-IL) 4. M/S. BECTON DICKINSON INDIA PVT. 2860 APPROVAL (F-RC) 5. M/S. BECTON DICKINSON INDIA PVT. 2860 APPROVAL (F-IL) 6. M/S. BIOMET ORTHOPAEDIC INDIA PVT. 17498 APPROVAL (E-IL) 7. M/S. BOSTON SCIENTIFIC INDIA PVT. 8788 APPROVAL (F-RC)

8. M/S. BOSTON SCIENTIFIC INDIA PVT. 8788 APPROVAL (F-IL) 9. M/S. BOSTON SCIENTIFIC INDIA PVT. 8788 10. M/S. CARDIO MEDICAL DEVICES PVT. 19043 APPROVAL (F-IL) 11. M/S. CARL ZEISS INDIA (BANGALORE ) PVT. 12. M/S. CARL ZEISS INDIA (BANGALORE ) PVT. 9926 APPROVAL (E-RC) 9926 APPROVAL (E-IL) 13. M/S. CLINICARE (INDIA) PVT. 17061 APPROVAL (F-IL) 14. M/S. COOK INDIA MEDICAL DEVICES PVT. 15957 APPROVAL (CT) 15. M/S. DEEP MEDICAL DEVICES PVT. 17600 APPROVAL (F-IL) 16. M/S. EURO MEDI TOOLS PVT. 17237 APPROVAL (F-IL) 17. M/S. GLOBAL SURGICALS PVT. 17496 APPROVAL (F-IL) 18. M/S. HESTER DIAGNOSTIC PVT. 17602 APPROVAL (F-IL) 19. M/S. INNVOLUTION HEALTHCARE PVT. 17601 APPROVAL (F-IL) 20. M/S. INNVOLUTION HEALTHCARE PVT. 17450 APPROVAL (F-IL) 21. M/S. INDIA MEDTRONIC PVT. 8441 APPROVAL (R-RC) 22. M/S. INDIA MEDTRONIC PVT. 8441 APPROVAL (R-IL) 23. M/S. JOHNSON & JOHNSON PVT. 15211 24. M/S. KOX MED & LAB PVT. 19042 APPROVAL (F-IL) 25. M/S. LIFELONG MEDITECH 27281 26. M/S. MERIT MEDICAL SYSTEMS INDIA PVT. 17598 APPROVAL (F-IL) 27. M/S. NOBEL BIOCARE INDIA PVT. 19721 APPROVAL (TL) 28. M/S. NOBEL BIOCARE INDIA PVT. 19720 APPROVAL (TL) 29. M/S. NOBEL BIOCARE INDIA PVT. 19719 APPROVAL (TL) 30. M/S. PAREKH INTEGRATED SERVICES PVT. 18558 APPROVAL (F-IL)

31. M/S. SHAH DISTRIBUTORS 19757 APPROVAL (R-IL) 32. M/S. SHUBHAN ENTERPRISES 17599 APPROVAL (F-IL) 33. M/S. SPINEMED SYSTEMS PVT. 17632 APPROVAL (R-IL) 34. M/S. TOTIPOTENT SC SCIENTIFIC PRODUCTS PVT. 35. M/S. VASCULAR THERAPEUTICS INDIA PVT. 18082 APPROVAL (E-IL) 17735 APPROVAL (F-IL) 36. M/S. WEALTH TAXI TECHNOLOGY PVT. 24702 CLARIFICATION 37. M/S. BECTON DICKINSON INDIA PVT. 7256 QUERY 38. M/S. AMARANTE WELLNESS ZONE 16454 CLARIFICATION 39. M/S. HEALTHY OPTION PVT. 16455 CLARIFICATION 40. M/S. STERICATGUTSRINGS PVT. 2052 41. M/S. B BRAUN MEDICAL (INDIA0 PVT. 27356 QUERY 42. M/S. TROIKAA PHARMACEUTICAL 24195 43. M/S. JOHNSON & JOHNSON PVT. 13397 44. M/S. JOHNSON & JOHNSON PVT. 15272 45. THE JOINT COMMISSIONER (KD), THANE (CLAA) 34181 QUERY DDC, CDSCO, MUMBAI (CLAA) M/S. GEORGE PHILIPS MEDICAL ENGINEERING PVT. 46. THE COMMISSIONER, GANDHINAGAR (CLAA) DDC, CDSCO, AHMEDABAD (GUJ.) (CLAA) 34111 APPROVAL M/S. BIOTECH VISION CARE PVT. 47. THE COMMISSIONER, GANDHINAGAR (CLAA) DDC, CDSCO, AHMEDABAD (GUJ.) (CLAA) 33087 APPROVAL

M/S. SAHAJANAND MEDICAL TECHNOLOGIES PVT. 48. M/S. S3V VASCULAR TECHNOLOGIES PVT. 49. M/S. S3V VASCULAR TECHNOLOGIES PVT. 4778 APPROVAL (F-RC) 4778 APPROVAL (F-IL) DIAGNOSTICS DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. AIMS 17048 APPROVAL (IL) 2. M/S. ALERE MEDICAL PVT. 15284 APPROVAL (E-IL) 3. M/S. ALLIED BIOTECHNOLOGY INDIA PVT. 15093 APPROVAL (IL) 4. M/S. ARKRAY HEALTHCARE PVT. 17163 APPROVAL (IL) 5. M/S. BECKMAN COULTER INDIA PVT. 16720 APPROVAL (IL) 6. M/S. BECKMAN COULTER INDIA PVT. 14042 APPROVAL (IL) 7. M/S. BECKMAN COULTER INDIA PVT. 14042 8. M/S. BIOMERIEUX INDIA PVT. 16586 9. M/S. BIOMERIEUX INDIA PVT. 14178 APPROVAL (IL) 10. M/S. BIO-RAD LABORATORIES (INDIA) PVT. 15907 APPROVAL (IL) 11. M/S. DHR HOLDING INDIA PVT. 16221 APPROVAL (IL) 12. M/S. EURO DIAGNOSTIC SYSTEMS PVT. 15808 APPROVAL (E-IL) 13. M/S. HALYARD HEALTH INDIA PVT. 14737 APPROVAL (IL)

14. M/S. IMMUCOR INDIA PVT. 15740 APPROVAL (IL) 15. M/S. JOHNSON & JOHNSON PVT. 16498 16. M/S. KRYPTON BIOMEDICAL PVT. 17076 APPROVAL (IL) 17. M/S. LILAC MEDICARE PVT. 14807 APPROVAL (IL) 18. M/S. LILAC MEDICARE PVT. 14807 19. M/S. LILAC MEDICARE PVT. 14806 20. M/S. LILAC MEDICARE PVT. 14808 APPROVAL (E-IL) 21. M/S. LILAC MEDICARE PVT. 14809 APPROVAL (E-IL) 22. M/S. PAMMVI EXPORTS PVT. 14852 APPROVAL (IL) 23. M/S. PINKI SCIENTIFIC 14467 APPROVAL (IL) 24. M/S. ROCHE DIAGNOSTICS INDIA PVT. 15712 APPROVAL (E-IL) 25. M/S. ROCHE DIAGNOSTICS INDIA PVT. 16722 APPROVAL (E-IL) 26. M/S. SANDOR MEDICAIDSPVT. 14048 APPROVAL (IL) 27. M/S. SIEMENS LIMITED 14877 APPROVAL (IL) 28. M/S. SIEMENS LIMITED 13987 APPROVAL (IL) 29. M/S. SIEMENS LIMITED 15226 APPROVAL (IL) 30. M/S. SIEMENS LIMITED 15225 APPROVAL (E-IL) 31. M/S. SIEMENS LIMITED 14770 APPROVAL (IL) 32. M/S. SIEMENS LIMITED 14499 APPROVAL (E-IL) 33. M/S. SYSMEX INDIA PVT. 14783 APPROVAL (IL) 34. M/S. TRANSASIA BIO-MEDICALS LIMITED 15067 APPROVAL (IL) 35. M/S. TRANSASIA BIO-MEDICALS LIMITED 16752 APPROVAL (IL) 36. M/S. TRANSASIA BIO MEDICALS LIMITED 17123 APPROVAL (E-IL) 37. M/S. TRIVITRON HEALTHCARE PVT. 12391 APPROVAL (IL) 38. M/S. TRIVITRON HEALTHCARE PVT. 15647 APPROVAL (IL) 39. M/S. UNIQUE DIAGNOSTICS & SCIENTIFIC 15630 APPROVAL (IL)

40. M/S. WERFEN MEDICAL INDIA PVT. 17043 APPROVAL (IL) 41. M/S. ATHENESEDX PVT. 18855 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT., NAVI MUMBAI-400 709 2. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT., NAVI MUMBAI-400 709 3. M/S. ALEMBIC PHARMACEUTICALS, VADODARA-390 003 4. M/S. APOTEX RESEARCH PVT., BANGALORE-560 099 5. M/S. AZIDUS LABORATORIES, CHENNAI- 600 048 6. M/S. CADILA HEALTHCARE,, AHMEDABAD-380 015 21605 AMENDMENT 21606 TEST LICENCE 21297 AMENDMENT 21802 TEST LICENCE 21630 TEST LICENCE 21768 TEST LICENCE 7. M/S. CIPLA LIMITED, MUMBAI-400 013 21691 APPROVAL 8. M/S. CIPLA LIMITED, MUMBAI-400 013 12900 TEST LICENCE 9. M/S. CIPLA LIMITED, MUMBAI-400 013 21686 TEST LICENCE 10. M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD-380 054 11. M/S. HIGLANCE LABORATORIES PVT., GREATER NOIDA-201306, U.P. 12. M/S. LOTUS LABS PVT., BANGALORE-560 034 13. M/S. LUPIN LIMITED (RESEARCH PARK), PUNE- 412 115 21609 AMENDMENT 21569 APPROVAL 21619 TEST LICENCE 21455 AMENDMENT

14. M/S. MANIPAL ACUNOVA, MANGALORE- 575 001 15. M/S. QUEST LIFE SCIENCES (P), CHENNAI- 600045 16. M/S. SEMLER RESEARCH CENTER, BANGALORE-560078 17. M/S. SYNGENE INTERNATIONAL, BANGALORE-560 100 18. M/S. WATSON PHARMA PVT., NAVI MUMBAI-400614 19. M/S. WATSON PHARMA PVT., NAVI MUMBAI-400614 20. M/S. WATSON PHARMA PVT., NAVI MUMBAI-400614 17830 APPROVAL 14893 APPROVAL 21607 AMENDMENT 21470 CLARIFICATION 21621 APPROVAL 21623 APPROVAL 21622 APPROVAL